1717 – Extravascular implantable cardioverter therapy for patients at risk of ventricular arrhythmia

Page last updated: 26 May 2022

Application Detail

Description of Medical Service

Extravascular implantable cardioverter defibrillaton (EV-ICD) is an alternative option for patients where traditional transvenous ICD is not ideal or feasible. For single-chamber EV-ICD, a battery-powered pulse generator is implanted in a pouch under the skin near the serratus muscle, found on the ribs on the left side. The electrode runs from the pulse generator to the anterior mediastinum, the front part of the chest between the lungs. If an abnormal heart rhythm is detected, the device will deliver an electric current to the heart, known as defibrillation, to restore a normal heartbeat.

Description of Medical Condition

Ventricular arrhythmias are abnormal heartbeats that originate from the lower heart chambers, known as ventricles. These types of arrhythmias cause the heart to beat too fast, which prevents oxygen-rich blood from circulating to the brain and body and may result in sudden cardiac death. The most common types of ventricular arrythmias are ventricular tachycardia and ventricular fibrillation.

Reason for Application

New MBS item

Medical Service Type

Therapeutic technology

Previous Application Number/s

Not Applicable

Associated Documentation

Application Form

Application Form (PDF 498 KB)
Application Form (Word 148 KB)

Consultation Survey

Consultation Survey (PDF 323 KB)
Consultation Survey (Word 72 KB)

PASC Consultation
PASC consultation closes 8 July 2022

MSAC Consultation
MSAC consultation TBA – please subscribe to the MSAC Email Bulletin to be notified when consultation opens for this application

For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process

PICO Confirmation

-

Assessment Report

-

Public Summary Document

-

Meetings for this Application

PASC

11–12 August 2022

ESC

-

MSAC

-